Cargando…

VirusLab: A Tool for Customized SARS-CoV-2 Data Analysis

Since the beginning of 2020, the COVID-19 pandemic has posed unprecedented challenges to viral data analysis and connected host disease diagnostic methods. We propose VirusLab, a flexible system for analysing SARS-CoV-2 viral sequences and relating them to metadata or clinical information about the...

Descripción completa

Detalles Bibliográficos
Autores principales: Pinoli, Pietro, Bernasconi, Anna, Sandionigi, Anna, Ceri, Stefano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9245481/
https://www.ncbi.nlm.nih.gov/pubmed/35822801
http://dx.doi.org/10.3390/biotech10040027
_version_ 1784738747302019072
author Pinoli, Pietro
Bernasconi, Anna
Sandionigi, Anna
Ceri, Stefano
author_facet Pinoli, Pietro
Bernasconi, Anna
Sandionigi, Anna
Ceri, Stefano
author_sort Pinoli, Pietro
collection PubMed
description Since the beginning of 2020, the COVID-19 pandemic has posed unprecedented challenges to viral data analysis and connected host disease diagnostic methods. We propose VirusLab, a flexible system for analysing SARS-CoV-2 viral sequences and relating them to metadata or clinical information about the host. VirusLab capitalizes on two existing resources: ViruSurf, a database of public SARS-CoV-2 sequences supporting metadata-driven search, and VirusViz, a tool for visual analysis of search results. VirusLab is designed for taking advantage of these resources within a server-side architecture that: (i) covers pipelines based on approaches already in use (ARTIC, Galaxy) but entirely cutomizable upon user request; (ii) predigests analysis of raw sequencing data from different platforms (Oxford Nanopore and Illumina); (iii) gives access to public archives datasets; (iv) supplies user-friendly reporting – making it a tool that can also be integrated into a business environment. VirusLab can be installed and hosted within the premises of any organization where information about SARS-CoV-2 sequences can be safely integrated with information about hosts (e.g., clinical metadata). A system such as VirusLab is not currently available in the landscape of similar providers: our results show that VirusLab is a powerful tool to generate tabular/graphical and machine readable reports that can be integrated in more complex pipelines. We foresee that the proposed system can support many research-oriented and therapeutic scenarios within hospitals or the tracing of viral sequences and their mutational processes within organizations for viral surveillance.
format Online
Article
Text
id pubmed-9245481
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-92454812022-07-06 VirusLab: A Tool for Customized SARS-CoV-2 Data Analysis Pinoli, Pietro Bernasconi, Anna Sandionigi, Anna Ceri, Stefano BioTech (Basel) Article Since the beginning of 2020, the COVID-19 pandemic has posed unprecedented challenges to viral data analysis and connected host disease diagnostic methods. We propose VirusLab, a flexible system for analysing SARS-CoV-2 viral sequences and relating them to metadata or clinical information about the host. VirusLab capitalizes on two existing resources: ViruSurf, a database of public SARS-CoV-2 sequences supporting metadata-driven search, and VirusViz, a tool for visual analysis of search results. VirusLab is designed for taking advantage of these resources within a server-side architecture that: (i) covers pipelines based on approaches already in use (ARTIC, Galaxy) but entirely cutomizable upon user request; (ii) predigests analysis of raw sequencing data from different platforms (Oxford Nanopore and Illumina); (iii) gives access to public archives datasets; (iv) supplies user-friendly reporting – making it a tool that can also be integrated into a business environment. VirusLab can be installed and hosted within the premises of any organization where information about SARS-CoV-2 sequences can be safely integrated with information about hosts (e.g., clinical metadata). A system such as VirusLab is not currently available in the landscape of similar providers: our results show that VirusLab is a powerful tool to generate tabular/graphical and machine readable reports that can be integrated in more complex pipelines. We foresee that the proposed system can support many research-oriented and therapeutic scenarios within hospitals or the tracing of viral sequences and their mutational processes within organizations for viral surveillance. MDPI 2021-11-06 /pmc/articles/PMC9245481/ /pubmed/35822801 http://dx.doi.org/10.3390/biotech10040027 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Pinoli, Pietro
Bernasconi, Anna
Sandionigi, Anna
Ceri, Stefano
VirusLab: A Tool for Customized SARS-CoV-2 Data Analysis
title VirusLab: A Tool for Customized SARS-CoV-2 Data Analysis
title_full VirusLab: A Tool for Customized SARS-CoV-2 Data Analysis
title_fullStr VirusLab: A Tool for Customized SARS-CoV-2 Data Analysis
title_full_unstemmed VirusLab: A Tool for Customized SARS-CoV-2 Data Analysis
title_short VirusLab: A Tool for Customized SARS-CoV-2 Data Analysis
title_sort viruslab: a tool for customized sars-cov-2 data analysis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9245481/
https://www.ncbi.nlm.nih.gov/pubmed/35822801
http://dx.doi.org/10.3390/biotech10040027
work_keys_str_mv AT pinolipietro viruslabatoolforcustomizedsarscov2dataanalysis
AT bernasconianna viruslabatoolforcustomizedsarscov2dataanalysis
AT sandionigianna viruslabatoolforcustomizedsarscov2dataanalysis
AT ceristefano viruslabatoolforcustomizedsarscov2dataanalysis